Hypoxanthine-<wbr/>d<sub>4</sub>

Hypoxanthine-d4

CAT N°: 36330
Price:

From 60.00 51.00

Hypoxanthine-d4 is intended for use as an internal standard for the quantification of hypoxanthine (Item No. 22254) by GC- or LC-MS. Hypoxanthine is an endogenous purine derivative and the major purine involved in the purine salvage pathway in the brain.{39146} Intrastriatal administration of hypoxanthine (10 µM) increases mitochondrial complex II, also known as succinate dehydrogenase, activity and decreases cytochrome c oxidase activity, resulting in neuroenergetic impairment, ATP depletion, and cellular apoptosis in rats. Hypoxanthine also induces hyperuricemia in mice.{39147} Spinal fluid levels of hypoxanthine are increased in patients with Lesh-Nyhan syndrome, an inborn error of metabolism characterized by cognitive deficits, motor dysunction, self-mutilation, and hyperuricemia.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 1,9-dihydro-1,9-d2-6H-purin-6-one-2,8-d2
  • Correlated keywords
    • deuterated deuterium GCMS LCMS NSC 14665 NSC 129419 NSC14665 NSC129419 hydroxy purine
  • Product Overview:
    Hypoxanthine-d4 is intended for use as an internal standard for the quantification of hypoxanthine (Item No. 22254) by GC- or LC-MS. Hypoxanthine is an endogenous purine derivative and the major purine involved in the purine salvage pathway in the brain.{39146} Intrastriatal administration of hypoxanthine (10 µM) increases mitochondrial complex II, also known as succinate dehydrogenase, activity and decreases cytochrome c oxidase activity, resulting in neuroenergetic impairment, ATP depletion, and cellular apoptosis in rats. Hypoxanthine also induces hyperuricemia in mice.{39147} Spinal fluid levels of hypoxanthine are increased in patients with Lesh-Nyhan syndrome, an inborn error of metabolism characterized by cognitive deficits, motor dysunction, self-mutilation, and hyperuricemia.

We also advise you